Bob Zutaut, RPh
Advertisement
Bob Zutaut, RPh, is director of clinical services at McKesson.
Articles by Bob Zutaut, RPh
Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.
Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.
Advertisement
Latest Updated Articles
Offering Specialty Infusions May Be Worth the Work for Oncology PracticesPublished: November 7th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
5